CME Group Inc. (CME)Â
NASDAQ$263.35
Market Cap
$94.9B
Sector
Financial Services
Industry
Financial—Data & Stock Exchanges
Rank in Sector
88 of 637
Rank in Industry
2 of 11
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
CME Insider Trading Activity
CME Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $580,826 | 5 | 20 |
Sells | $31,303,378 | 20 | 80 |
Related Transactions
| SHEPARD WILLIAM R | director | 5 | $580,826 | 0 | $0 | $580,826 |
| GEPSMAN MARTIN J | director | 0 | $0 | 1 | $89,168 | $-89,168 |
| GLICKMAN DANIEL R | director | 0 | $0 | 1 | $130,937 | $-130,937 |
| Fitzpatrick Lynne | Sr MD Chief Financial Officer | 0 | $0 | 1 | $163,610 | $-163,610 |
| Bitsberger Timothy S. | director | 0 | $0 | 1 | $226,957 | $-226,957 |
| McCourt Timothy Francis | Sr MD Global Head Equity & FX | 0 | $0 | 1 | $312,056 | $-312,056 |
| Cook Elizabeth A | director | 0 | $0 | 2 | $381,271 | $-381,271 |
| Sprague Suzanne | COO & Global Head of Clearing | 0 | $0 | 1 | $385,249 | $-385,249 |
| Lucas Deborah J | director | 0 | $0 | 1 | $385,425 | $-385,425 |
| SAVAGE TERRY L | director | 0 | $0 | 1 | $526,620 | $-526,620 |
| Carey Charles P | director | 0 | $0 | 1 | $586,320 | $-586,320 |
| Cutinho Sunil | Chief Information Officer | 0 | $0 | 1 | $1.02M | $-1.02M |
| Vroman Ken | Chief Transformation Officer | 0 | $0 | 1 | $1.27M | $-1.27M |
| Durkin Bryan T | director | 0 | $0 | 1 | $1.63M | $-1.63M |
| Piell Hilda Harris | Sr MD & Chief HR Officer | 0 | $0 | 2 | $2.5M | $-2.5M |
| SIEGEL HOWARD J | director | 0 | $0 | 1 | $2.6M | $-2.6M |
| Winkler Julie | Sr MD Chief Commercial Officer | 0 | $0 | 1 | $2.89M | $-2.89M |
| DUFFY TERRENCE A | Chairman and CEO | 0 | $0 | 2 | $16.21M | $-16.21M |
About CME Group Inc.
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.
Insider Activity of CME Group Inc.
Over the last 12 months, insiders at CME Group Inc. have bought $580,826 and sold $31.3M worth of CME Group Inc. stock.
On average, over the past 5 years, insiders at CME Group Inc. have bought $2.22M and sold $22.88M worth of stock each year.
Highest buying activity among insiders over the last 12 months: SHEPARD WILLIAM R (director) — $580,826.
The last purchase of 1,429 shares for transaction amount of $325,798 was made by SHEPARD WILLIAM R (director) on 2025‑01‑16.
List of Insider Buy and Sell Transactions, CME Group Inc.
| 2025-03-14 | Sale | Lucas Deborah J | director | 1,500 0.0004% | $256.95 | $385,425 | +2.62% | |
| 2025-03-13 | Sale | SIEGEL HOWARD J | director | 10,000 0.0028% | $260.00 | $2.6M | +1.80% | |
| 2025-03-11 | Sale | DUFFY TERRENCE A | Chairman and CEO | 30,000 0.0083% | $259.18 | $7.78M | +1.17% | |
| 2025-03-03 | Sale | Sprague Suzanne | COO & Global Head of Clearing | 1,500 0.0004% | $256.83 | $385,249 | +1.26% | |
| 2025-02-27 | Sale | Piell Hilda Harris | Sr MD & Chief HR Officer | 3,984 0.0011% | $250.47 | $997,853 | +3.77% | |
| 2025-02-13 | Sale | Winkler Julie | Sr MD Chief Commercial Officer | 11,592 0.0032% | $249.17 | $2.89M | +1.75% | |
| 2025-02-13 | Sale | Vroman Ken | Chief Transformation Officer | 5,066 0.0014% | $250.00 | $1.27M | +1.75% | |
| 2025-01-16 | SHEPARD WILLIAM R | director | 1,429.19 0.0004% | $227.96 | $325,798 | +6.76% | ||
| 2024-12-27 | SHEPARD WILLIAM R | director | 276.02 <0.0001% | $232.89 | $64,282 | +4.76% | ||
| 2024-11-12 | Sale | Cook Elizabeth A | director | 750 0.0002% | $226.33 | $169,751 | +6.25% | |
| 2024-11-04 | Sale | GEPSMAN MARTIN J | director | 400 0.0001% | $222.92 | $89,168 | +7.73% | |
| 2024-10-30 | Sale | Cutinho Sunil | Chief Information Officer | 4,500 0.0012% | $226.64 | $1.02M | +5.46% | |
| 2024-10-30 | Sale | Bitsberger Timothy S. | director | 1,000 0.0003% | $226.96 | $226,957 | +5.46% | |
| 2024-10-28 | Sale | McCourt Timothy Francis | Sr MD Global Head Equity & FX | 1,374 0.0004% | $227.12 | $312,056 | +5.05% | |
| 2024-09-25 | SHEPARD WILLIAM R | director | 292.65 <0.0001% | $218.50 | $63,945 | +9.57% | ||
| 2024-09-15 | Sale | Fitzpatrick Lynne | Sr MD Chief Financial Officer | 754 0.0002% | $216.99 | $163,610 | -0.08% | |
| 2024-08-30 | Sale | Durkin Bryan T | director | 7,593 0.0021% | $214.59 | $1.63M | +10.28% | |
| 2024-06-25 | SHEPARD WILLIAM R | director | 325.88 <0.0001% | $195.07 | $63,569 | +17.59% | ||
| 2024-06-13 | Sale | Carey Charles P | director | 3,000 0.0008% | $195.44 | $586,320 | +16.20% | |
| 2024-06-06 | Sale | GLICKMAN DANIEL R | director | 650 0.0002% | $201.44 | $130,937 | +13.23% |
Total: 746
*Gray background shows transactions not older than one year
Insider Historical Profitability
14%
| SHEPARD WILLIAM R | director | 256805 0.0713% | $67.63M | 28 | 6 | +17.66% |
| Durkin Bryan T | director | 55607 0.0154% | $14.64M | 0 | 19 | |
| DUFFY TERRENCE A | Chairman and CEO | 53205 0.0148% | $14.01M | 3 | 26 | +4.33% |
| Piell Hilda Harris | Sr MD & Chief HR Officer | 27046 0.0075% | $7.12M | 0 | 33 | |
| Cutinho Sunil | Chief Information Officer | 27053 0.0075% | $7.12M | 0 | 8 | |
| GEPSMAN MARTIN J | director | 25067 0.007% | $6.6M | 0 | 31 | |
| SIEGEL HOWARD J | director | 21873 0.0061% | $5.76M | 0 | 11 | |
| Winkler Julie | Sr MD Chief Commercial Officer | 21885 0.0061% | $5.76M | 0 | 10 | |
| Cook Elizabeth A | director | 18239 0.0051% | $4.8M | 0 | 8 | |
| SAVAGE TERRY L | director | 17441 0.0048% | $4.59M | 1 | 1 | +19.17% |
| Vroman Ken | Chief Transformation Officer | 16715 0.0046% | $4.4M | 0 | 4 | |
| GLICKMAN DANIEL R | director | 14008 0.0039% | $3.69M | 0 | 7 | |
| Fitzpatrick Lynne | Sr MD Chief Financial Officer | 13261 0.0037% | $3.49M | 0 | 1 | |
| Bitsberger Timothy S. | director | 10589 0.0029% | $2.79M | 0 | 8 | |
| Sprague Suzanne | COO & Global Head of Clearing | 8036 0.0022% | $2.12M | 0 | 2 | |
| Carey Charles P | director | 7163 0.002% | $1.89M | 2 | 18 | +3.12% |
| McCourt Timothy Francis | Sr MD Global Head Equity & FX | 7275 0.002% | $1.92M | 0 | 5 | |
| Lucas Deborah J | director | 3356 0.0009% | $883,802.60 | 0 | 1 | |
| MCNULTY JAMES J | President & CEO | 135214 0.0375% | $35.61M | 0 | 2 | |
| GILL PHUPINDER | CEO | 116222 0.0323% | $30.61M | 1 | 26 | +12.28% |
| TAYLOR KIMBERLY S | Former Sr MD&Pres.Clr&PostTrad | 112465 0.0312% | $29.62M | 0 | 41 | |
| Kometer Kevin | Sr MD Chief Information Office | 63207 0.0175% | $16.65M | 0 | 9 | |
| Parisi James E. | CFO & Sr MD Finance & Corp Dev | 47810 0.0133% | $12.59M | 1 | 11 | <0.0001% |
| Bernacchi Jeffrey M. | director | 42004 0.0117% | $11.06M | 0 | 6 | |
| Pietrowicz John W. | Sr MD Chief Financial Officer | 42330 0.0117% | $11.15M | 0 | 23 | |
| CRONIN KATHLEEN M | Sr MD Gen Counsel & Corp Secr | 40368 0.0112% | $10.63M | 0 | 31 | |
| OLIFF JAMES E | director | 35761 0.0099% | $9.42M | 1 | 21 | +15.65% |
| Holzrichter Julie | Sr MD Chief Operating Officer | 31990 0.0089% | $8.42M | 0 | 16 | |
| SANDNER JOHN F | director | 30000 0.0083% | $7.9M | 0 | 9 | |
| DONOHUE CRAIG S | CEO | 26734 0.0074% | $7.04M | 1 | 18 | +47.32% |
| Tully Sean | Sr MD Global Hd Financial & OT | 22032 0.0061% | $5.8M | 0 | 6 | |
| Donaldson James A | director | 20093 0.0056% | $5.29M | 0 | 6 | |
| Tobin Jack J | MD Chief Accounting Officer | 15754 0.0044% | $4.15M | 0 | 5 | |
| Zagotta Robert | Sr MD Strategy & Execution | 12375 0.0034% | $3.26M | 0 | 2 | |
| POLLOCK ALEX J | director | 11502 0.0032% | $3.03M | 2 | 0 | +33.74% |
| Tierney Robert J JR | director | 11609 0.0032% | $3.06M | 1 | 0 | +9.74% |
| Paulhac Laurent | Sr MD IR & OTC Prod & Svcs | 11175 0.0031% | $2.94M | 0 | 1 | |
| Pietrzak John L | director | 10702 0.003% | $2.82M | 0 | 3 | |
| MELAMED LEO | director | 10537 0.0029% | $2.77M | 0 | 8 | |
| SALATICH WILLIAM G JR | director | 10612 0.0029% | $2.79M | 0 | 3 | |
| Harley Jill A | MD & CAO | 10191 0.0028% | $2.68M | 0 | 12 | |
| GORDON SCOTT | director | 9000 0.0025% | $2.37M | 0 | 1 | |
| Rich Linda Dallas | Sr MD Govt Rel Legisl Affairs | 8039 0.0022% | $2.12M | 0 | 4 | |
| CLEGG JACKIE M | director | 7155 0.002% | $1.88M | 0 | 3 | |
| REDDING RICHARD H | MD Products & Services | 7165 0.002% | $1.89M | 0 | 11 | |
| Chadid Mazen | MD Operations | 5860 0.0016% | $1.54M | 0 | 8 | |
| Niciforo Joseph | director | 5137 0.0014% | $1.35M | 3 | 11 | <0.0001% |
| GERDES LARRY G | director | 4501 0.0012% | $1.19M | 3 | 0 | +2.83% |
| Cermak Mark E | director | 4270 0.0012% | $1.12M | 0 | 5 | |
| Pankau Ronald A. | director | 3906 0.0011% | $1.03M | 0 | 20 | |
| Suskind Dennis | director | 3167 0.0009% | $834,029.45 | 0 | 11 | |
| Pieper James V. | MD & CAO, other: MD & CAO | 3069 0.0009% | $808,221.15 | 0 | 2 | |
| KRAUSE JAMES R | MD & CIO | 2835 0.0008% | $746,597.25 | 0 | 10 | |
| GOMACH DAVID G | MD & CFO | 2490 0.0007% | $655,741.50 | 0 | 2 | |
| Corvino Robert F | director | 2501 0.0007% | $658,671.27 | 0 | 19 | |
| KEEVE EILEEN | MD Organizational Development | 1735 0.0005% | $456,912.25 | 0 | 19 | |
| LYNCH PATRICK B | director | 1888 0.0005% | $497,204.80 | 3 | 11 | +21.08% |
| Newsome James E | director | 1796 0.0005% | $472,976.60 | 0 | 2 | |
| NANDAPURKAR SATISH | Managing Director | 1300 0.0004% | $342,355.00 | 0 | 3 | |
| KATLER GARY M | director | 1000 0.0003% | $263,350.00 | 0 | 18 | |
| ROBERTS JOHN ROTH III | MD & CMO | 1000 0.0003% | $263,350.00 | 0 | 1 | |
| GOBLE NANCY W | MD & CAO | 813 0.0002% | $214,103.55 | 0 | 25 | |
| MILLER WILLIAM P II | director | 100 0% | $26,335.00 | 1 | 0 | +46.77% |
| WESCOTT DAVID J | director | 1 0% | $263.35 | 3 | 0 | +0.42% |
| Odom C C II | director | 3 0% | $790.05 | 0 | 32 | |
| Sammann Derek | Sr MD Gl Hd Commodity & Option | 0 0% | $0 | 0 | 16 |
*Gray background shows insiders who have made transactions during last year
Historical Insider Profitability vs. Competitors
$2,604,369 | 27 | -14.17% | $22.63B | |
$452,075,618 | 21 | -8.17% | $3.85B |
CME Institutional Investors: Active Positions
| Increased Positions | 786 | +56.47% | 28M | +8.92% |
| Decreased Positions | 592 | -42.53% | 22M | -6.78% |
| New Positions | 198 | New | 8M | New |
| Sold Out Positions | 84 | Sold Out | 2M | Sold Out |
| Total Postitions | 1,586 | +13.94% | 325M | +2.14% |
CME Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Vanguard Group Inc | $8.86M | 9.51% | 34.24M | +326,623 | +0.96% | 2024-12-31 |
| Blackrock, Inc. | $7.66M | 8.23% | 29.62M | +821,736 | +2.85% | 2024-12-31 |
| State Street Corp | $4.17M | 4.47% | 16.1M | +203,443 | +1.28% | 2024-12-31 |
| Capital World Investors | $2.9M | 3.12% | 11.21M | -918,317 | -7.57% | 2024-12-31 |
| Morgan Stanley | $2.84M | 3.05% | 10.98M | -109,007 | -0.98% | 2024-12-31 |
| Jpmorgan Chase & Co | $2.79M | 3% | 10.79M | +337,063 | +3.22% | 2024-12-31 |
| Geode Capital Management, Llc | $2.17M | 2.33% | 8.39M | +104,697 | +1.26% | 2024-12-31 |
| Price T Rowe Associates Inc /Md/ | $2.14M | 2.3% | 8.28M | +4M | +89.95% | 2024-12-31 |
| Bank Of New York Mellon Corp | $1.65M | 1.77% | 6.37M | -27,557 | -0.43% | 2024-12-31 |
| Norges Bank | $1.23M | 1.33% | 4.77M | -45,513 | -0.94% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.